(Q39420410)

11 September 2017

1 reference

title

Remyelination therapies: a new direction and challenge in multiple sclerosis (English)

1 reference

11 September 2017

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28685761%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

V. Wee Yong

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28685761%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Wei-Qiao Liu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28685761%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

7 July 2017

1 reference

Nature Reviews Drug Discovery

11 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28685761%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28685761%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28685761%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

617-634

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28685761%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrd.2017.115

3 June 2020

exact match

0 references

cites work

Interactions between axons and their sheath cells

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Glial cells and the central myelin sheath

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Axon-glial signaling and the glial support of axon function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Myelination and the trophic support of long axons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Axonal swellings and degeneration in mice lacking the major proteolipid of myelin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Axonal protective effects of the myelin-associated glycoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Primary oligodendrocyte death does not elicit anti-CNS immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Targeted ablation of oligodendrocytes triggers axonal damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Late motor decline after accomplished remyelination: impact for progressive multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Oligodendroglia metabolically support axons and contribute to neurodegeneration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

The molecular physiology of the axo-myelinic synapse.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Oligodendroglial NMDA Receptors Regulate Glucose Import and Axonal Energy Metabolism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Demyelination induces transport of ribosome-containing vesicles from glia to axons: evidence from animal models and MS patient brains.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

The trophic role of oligodendrocytes in the basal forebrain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

A role for oligodendrocyte-derived IGF-1 in trophic support of cortical neurons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Sonic hedgehog--regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

A critical role for dorsal progenitors in cortical myelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Oligodendrocyte precursors migrate along vasculature in the developing nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Origin of new glial cells in intact and injured adult spinal cord.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Origin of oligodendrocytes in the subventricular zone of the adult brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Cell cycle dynamics of NG2 cells in the postnatal and ageing brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Rejuvenation of regeneration in the aging central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

SEQUENCE OF MYELINIZATION IN THE BRAIN OF THE ALBINO RAT. A. CEREBRAL CORTEX, THALAMUS AND RELATED STRUCTURES.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Dynamics of oligodendrocyte generation and myelination in the human brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Maturation of white matter in the human brain: a review of magnetic resonance studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Pre-Existing Mature Oligodendrocytes Do Not Contribute to Remyelination following Toxin-Induced Spinal Cord Demyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRD.2017.115

31 March 2020

12 December 2020

Synaptic vesicle release regulates myelin sheath number of individual oligodendrocytes in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Neuronal activity biases axon selection for myelination in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Activity-Dependent and Experience-Driven Myelination Provide New Directions for the Management of Multiple Sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Individual Neuronal Subtypes Exhibit Diversity in CNS Myelination Mediated by Synaptic Vesicle Release

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

CNS Myelin Sheath Lengths Are an Intrinsic Property of Oligodendrocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

A culture system to study oligodendrocyte myelination processes using engineered nanofibers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Neurite outgrowth inhibitor Nogo-A establishes spatial segregation and extent of oligodendrocyte myelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Notch receptor activation inhibits oligodendrocyte differentiation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Astrocyte-derived endothelin-1 inhibits remyelination through notch activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

LINGO-1 negatively regulates myelination by oligodendrocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Effect of Demyelination on Conduction in the Central Nervous System

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Internodal conduction in undissected demyelinated nerve fibres

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Conduction in myelinated, unmyelinated, and demyelinated fibers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Density of sodium channels in mammalian myelinated nerve fibers and nature of the axonal membrane under the myelin sheath

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Hypomyelination alters K+ channel expression in mouse mutants shiverer and Trembler

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Heteromultimeric K+ channels in terminal and juxtaparanodal regions of neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Overcoming conduction failure in demyelinated nerve fibres by prolonging action potentials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Impulse conduction in multiple sclerosis: a theoretical basis for modification by temperature and pharmacological agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

The effects of 4‐aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Extensive remyelination of the CNS leads to functional recovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Visual evoked potentials and MBP gene expression imply endogenous myelin repair in adult rat optic nerve and chiasm following local lysolecithin induced demyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Role of chondroitin sulfate proteoglycans in axonal conduction in Mammalian spinal cord

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Neutralization of inhibitory molecule NG2 improves synaptic transmission, retrograde transport, and locomotor function after spinal cord injury in adult rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Conduction in segmentally demyelinated mammalian central axons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Reorganization of the Axon Membrane in Demyelinated Peripheral Nerve Fibers: Morphological Evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Increased numbers of sodium channels form along demyelinated axons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Sodium channel expression within chronic multiple sclerosis plaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Remyelination protects axons from demyelination-associated axon degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Axonal protection using flecainide in experimental autoimmune encephalomyelitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Remyelination is extensive in a subset of multiple sclerosis patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Demyelination versus remyelination in progressive multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Multiple sclerosis: remyelination of nascent lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Remyelination can be extensive in multiple sclerosis despite a long disease course

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Pattern of remyelination in the CNS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Dynamic imaging of individual remyelination profiles in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Cortical lesions in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Grey Matter Pathology in Multiple Sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

A mouse model for testing remyelinating therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Subpial demyelination in the cerebral cortex of multiple sclerosis patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Accumulation of cortical lesions in MS: relation with cognitive impairment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Cortical remyelination: a new target for repair therapies in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Remyelination capacity of the MS brain decreases with disease chronicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Magnetization transfer ratio recovery in new lesions decreases during adolescence in pediatric-onset multiple sclerosis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Natural history of multiple sclerosis: a unifying concept

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Apoptosis of Oligodendrocytes during Early Development Delays Myelination and Impairs Subsequent Responses to Demyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Differences in the early inflammatory responses to toxin-induced demyelination are associated with the age-related decline in CNS remyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Inhibition of oligodendrocyte precursor cell differentiation by myelin-associated proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Remyelination in the CNS: from biology to therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Why does remyelination fail in multiple sclerosis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

LINGO-1, a transmembrane signaling protein, inhibits oligodendrocyte differentiation and myelination through intercellular self-interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Somatodendritic Expression of JAM2 Inhibits Oligodendrocyte Myelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Taking advantage of the systemic immune system to cure brain diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

The benefits and detriments of macrophages/microglia in models of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Axonal damage in acute multiple sclerosis lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Human oligodendrocytes are susceptible to cytolysis by major histocompatibility complex class I-restricted lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Direct and indirect effects of immune and central nervous system-resident cells on human oligodendrocyte progenitor cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Adaptive human immunity drives remyelination in a mouse model of demyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Galectin-1 circumvents lysolecithin-induced demyelination through the modulation of microglial polarization/phagocytosis and oligodendroglial differentiation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Regulatory T cells promote myelin regeneration in the central nervous system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

A regenerative approach to the treatment of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Muscarinic M1, M2 receptor binding. Relationship with functional efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Stimulant actions of histamine H1 antagonists on operant behavior in the squirrel monkey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Benztropine-induced release of dopamine from brain in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Comparative effects of benztropine and nomifensine on dopamine uptake and release from striatal synaptosomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-Cl in a mouse model of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Remyelination after cuprizone induced demyelination is accelerated in mice deficient in the polysialic acid synthesizing enzyme St8siaIV.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Pathophysiology of the brain extracellular matrix: a new target for remyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Early netrin-1 expression impairs central nervous system remyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Full-length and fragmented netrin-1 in multiple sclerosis plaques are inhibitors of oligodendrocyte precursor cell migration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

A new in vitro mouse oligodendrocyte precursor cell migration assay reveals a role for integrin-linked kinase in cell motility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Retinoid X receptor gamma signaling accelerates CNS remyelination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Inhibition of CNS remyelination by the presence of semaphorin 3A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Semaphorin CD100 from activated T lymphocytes induces process extension collapse in oligodendrocytes and death of immature neural cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Olesoxime accelerates myelination and promotes repair in models of demyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

High doses of biotin in chronic progressive multiple sclerosis: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Pregnancy, prolactin and white matter regeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Hematopoietic stem-cell transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Texture analysis of spinal cord pathology in multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Picturing multiple sclerosis: conventional and diffusion tensor imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Demyelination increases radial diffusivity in corpus callosum of mouse brain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Axial diffusivity is the primary correlate of axonal injury in the experimental autoimmune encephalomyelitis spinal cord: a quantitative pixelwise analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Magnetization transfer in MRI: a review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

MR relaxation in multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Myelin water imaging of multiple sclerosis at 7 T: Correlations with histopathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-¹¹C]-2-(4'-methylaminophenyl)- 6-hydroxybenzothiazole.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Imaging as an Outcome Measure in Multiple Sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Assessing remyelination - metabolic labeling of myelin in an animal model of multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Enhanced remyelination following lysolecithin-induced demyelination in mice under treatment with fingolimod (FTY720).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Ethidium bromide induced demyelination in the spinal cord of the cat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

The case for a central nervous system (CNS) origin for the Schwann cells that remyelinate CNS axons following concurrent loss of oligodendrocytes and astrocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Myelination of the mouse corpus callosum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

The relevance of animal models in multiple sclerosis research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2017.115

7 January 2021

inferred from DOI database lookup

Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.

1 reference

12 December 2020

Multiple sclerosis. Animal model:Theiler's virus infection in mice

1 reference

12 December 2020

Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus

1 reference

12 December 2020

Dissecting structure-function interactions in acute optic neuritis to investigate neuroplasticity.

1 reference

12 December 2020

The response of oligodendrocytes to chemical injury.

1 reference

12 December 2020

Chemical inducers and transcriptional markers of oligodendrocyte differentiation

1 reference

12 December 2020

MRI texture analysis in multiple sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRD.2017.115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28685761%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference